Atilla Arslanoglu MD, Presenter: Grant, Siemens AG

Adeel Rahim Seyal MD, Abstract Co-Author: Grant, Siemens AG

Azize Sahin MD, Abstract Co-Author: Nothing to Disclose

Fernanda Dias Gonzalez Guindalini MD, Abstract Co-Author: Nothing to Disclose

Frank H. Miller MD, Abstract Co-Author: Nothing to Disclose

Vahid Yaghmai MD, Abstract Co-Author: Nothing to Disclose

Hepatocellular carcinoma (HCC) is the most common primary liver tumor in adults. The American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), Liver Imaging Reporting and Data System (LI-RADS), Model for End Stage Liver Disease (MELD), Milan criteria, modified Response Evaluation Criteria in Solid Tumors (mRECIST), Organ Procurement and Transplant Network (OPTN) and United Network for Organ Sharing (UNOS) have laid down guidelines for HCC. Our exhibit will review how and what these guidelines/organizations mean to the practice of abdominal imaging. This exhibit will “unlock” the current complexities of this process and familiarize abdominal radiologists with nuances that affect management of patients with chronic liver disease at risk for HCC.

• Brief introduction of the guidelines • Diagnosis of HCC based on the available recommendations • Guidelines used to determine treatment and response assessment of HCC • Policies to decide liver transplant allocation in patients with HCC • Comparison between different practice guidelines • Role of these criteria in clinical radiology • Pitfalls of different guidelines  

http://abstract.rsna.org/uploads/2014/14013955/14013955_jmaq.pdf

Arslanoglu, A, Seyal, A, Sahin, A, Gonzalez Guindalini, F, Miller, F, Yaghmai, V, What You Need to Know About the Alphabet Soup of Hepatocellular Carcinoma Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14013955.html